Dr. Julio M. Pimentel is an accomplished cancer biologist and clinical researcher specializing in translational medicine. With a robust background in studying resistance mechanisms in cancer therapies, Dr. Pimentel has significantly contributed to understanding and overcoming resistance in triple-negative breast cancer (TNBC) and pancreatic cancer. Currently, he serves as an Institutional Research Academic Career Development Award (IRACDA) Postdoctoral Fellow at the University of California, San Diego. His work is aimed at improving cancer treatment outcomes and expanding leadership diversity in STEM fields.
Profile 📄
For more details on Dr. Julio M. Pimentel’s academic and professional journey, visit his LinkedIn profile.
Education 🎓
Doctor of Philosophy in Cancer Biology (2023), Wayne State University School of Medicine. Dissertation: “The Mechanisms of TRAIL Resistance in Triple-Negative Breast Cancer.”
Master of Science in Clinical Investigation and Translational Medicine (2018), University of Miami Miller School of Medicine. Thesis: “Metabolic Reprogramming with Beta-Alanine to Overcome Gemcitabine Resistance in Pancreatic Cancer.”
Bachelor of Science in Biological Sciences (2014), California State University Stanislaus, with concentrations in Molecular Biology & Microbiology and a Minor in Chemistry.
Experience 🧑🔬
IRACDA Postdoctoral Fellow (2023-Present), University of California San Diego. Research on endothelial cytoprotective signaling.
Ph.D. Graduate Research Assistant (2019-2023), Barbara Ann Karmanos Institute & Wayne State University. Investigated mechanisms of TRAIL resistance in TNBC.
MSCTI Graduate Research Assistant (2016-2018), University of Miami & Sylvester Comprehensive Cancer Center. Focused on overcoming chemoresistance in pancreatic cancer.
Instructional Student Assistant (2012-2016), California State University Stanislaus. Tutored students in various scientific disciplines.
Licensed Nurse Aide (2012-2013), Covenant Care at Home & Emanuel Medical Center. Provided end-of-life care.
Research Interests 🔬
Dr. Pimentel’s research interests include cancer biology, mechanisms of drug resistance, translational medicine, and immunotherapy. His work primarily focuses on identifying and targeting resistance pathways in aggressive cancers, such as TNBC and pancreatic cancer, to improve therapeutic efficacy and patient outcomes.
Awards 🏆
UCSD Institutional Research Academic Career Development Award (2025-2023)
Leonard N. Simons Award (2023)
Oakland County Executive’s Oakland Together 40 Under 40 Class of 2023
Top 100 Innovators and Entrepreneurs by The Top 100 Magazine (2022)
National Latino Leader Award by the National Diversity Council (2021)
Publications Top Notes 📚
Targeting PP2A to Overcome TRAIL Resistance in TNBC Cells (Published in Journal of Cancer Research, 2023) [Cited by 25 articles].
p62/SQSTM1 as a Critical Player in PARP Inhibitor Resistance in Triple-Negative Breast Cancer (Published in Molecular Carcinogenesis, 2022) [Cited by 18 articles].
RNA-seq Identifies Inflammatory Pathways to Confer TRAIL Resistance in TNBC Cells (Under Peer Review, 2023).